NYSE:OXY
NYSE:OXYOil and Gas

Occidental Petroleum (OXY) Valuation Check As New Carbon Removal Deal Underscores Growing Carbon Management Ambitions

Occidental Petroleum (OXY) is back in focus after its carbon capture subsidiary, 1PointFive, agreed to sell 9,000 metric tons of Direct Air Capture carbon removal credits to Bain & Company over a three-year period. See our latest analysis for Occidental Petroleum. That 1PointFive deal lands at a time when interest in Occidental’s carbon management story is building again, with a 7 day share price return of 8.12% and a 30 day share price return of 10.28%, even though the 1 year total...
NasdaqCM:EOSE
NasdaqCM:EOSEElectrical

Assessing Eos Energy Enterprises (EOSE) Valuation After Eos Indensity Launch And Upcoming Eos In Focus Webcast

Eos Energy Enterprises (EOSE) is back in focus after unveiling its new Eos Indensity architecture and preparing for its “Eos in Focus” webcast, events that are concentrating attention on the stock and the underlying business. See our latest analysis for Eos Energy Enterprises. Those product and event updates come after a period of sharp moves, with a 7 day share price return of 23.75% and a year to date share price return of 33.38%. This is set against a 1 year total shareholder return of...
NYSE:NATL
NYSE:NATLDiversified Financial

Did NCR Atleos’ Greek ATM-as-a-Service Deal Just Reframe NATL’s Bank Partnership Strategy?

NCR Atleos Corporation recently announced a collaboration with Epirus Bank to modernize the bank’s ATM network across Greece using its ATM as a Service model, including lifecycle services such as location selection, installation, maintenance, and operational support for new co-branded Epirus Bank–Cashzone ATMs. This agreement highlights how NCR Atleos can deepen its presence in European markets by running outsourced, branded ATM networks that help banks cut operating complexity while...
NYSE:BAC
NYSE:BACBanks

Bank Of America (BAC) Earnings Growth And 27% Margin Reinforce Bullish Profit Narratives

Bank of America (BAC) FY 2025 earnings snapshot Bank of America (BAC) has wrapped up FY 2025 with fourth quarter revenue of US$27.1b and basic EPS of US$0.99, supported by trailing twelve month revenue of US$107.4b and EPS of US$3.86. The bank has seen revenue move from US$96.1b and EPS of US$3.25 on a trailing basis at the end of 2024 to US$107.4b and US$3.86 respectively, while FY 2025 net income excluding extra items came in at US$29.1b. Together with a trailing net profit margin of 27%...
NYSE:BORR
NYSE:BORREnergy Services

Do New Ran and Odin Contracts Clarify Borr Drilling’s (BORR) Long-Term Fleet Utilization Story?

Borr Drilling Limited recently announced new contract commitments for its Ran and Odin jack-up rigs, extending work in Mexico through March 2026 and securing a multi-well campaign in the United States starting in mid-2026. These contracts add visibility to Borr Drilling's future workload and highlight continued customer demand for its premium shallow-water fleet in the Americas. Next, we’ll examine how this added contract visibility for the Ran and Odin rigs influences Borr Drilling’s...
NYSE:FDS
NYSE:FDSCapital Markets

A Look At FactSet Research Systems (FDS) Valuation After New US$1.2b ESOP Shelf Registration Filing

Why FactSet’s new shelf registration matters for shareholders FactSet Research Systems (FDS) has filed a shelf registration for up to US$1.245b in common stock, tied to an ESOP related offering of 4,232,362 shares. This filing is drawing fresh attention to potential dilution and capital allocation. See our latest analysis for FactSet Research Systems. The shelf registration lands after a mixed stretch for investors, with a 90 day share price return of 6.21% and a 1 year total shareholder...
NasdaqCM:TGTX
NasdaqCM:TGTXBiotechs

A Look At TG Therapeutics (TGTX) Valuation After New BRIUMVI Revenue Guidance At J.P. Morgan Conference

TG Therapeutics (TGTX) drew attention after using its J.P. Morgan Healthcare Conference slot to share preliminary 2025 revenue figures for BRIUMVI and to outline 2026 revenue targets, giving investors fresh information on current business momentum. See our latest analysis for TG Therapeutics. The revenue guidance shared at the J.P. Morgan Healthcare Conference comes after a 1-day share price return of 5.99% to US$29.54, compared with a 30-day share price decline of 5.95%. The three year total...
NasdaqGS:HOOD
NasdaqGS:HOODCapital Markets

Is Robinhood Markets (HOOD) Still Worth Considering After Its Strong Multi Year Rally

If you are wondering whether Robinhood Markets at US$119.67 is still offering value after its big run, this article will walk through what the current price may be implying. The stock has returned 3.7% over the last 7 days, 0.2% over the last 30 days, 3.9% year to date, 159.7% over the last year, and a very large 3 year return. Recent discussion around Robinhood has focused on its role as a major retail trading platform and how that positioning could affect investor expectations, especially...
NYSE:RACE
NYSE:RACEAuto

Is Ferrari (RACE) Still Worth Its Premium After Recent Share Price Weakness

If you have ever wondered whether Ferrari shares still justify their premium price tag, you are not alone, as many investors are asking what a fair value looks like today. The stock last closed at US$353.39, with a 3.7% decline over 7 days, a 4.1% decline over 30 days, a 5.0% decline year to date, but a 50.6% gain over 3 years and 70.9% over 5 years. These mixed returns over different time frames have kept Ferrari on many watchlists, as investors reassess what they are willing to pay for the...
NasdaqGM:VCYT
NasdaqGM:VCYTBiotechs

Is Veracyte’s 2026 Growth Guidance And New US Launches Altering The Investment Case For Veracyte (VCYT)?

In January 2026, Veracyte released preliminary, unaudited results and earnings guidance, projecting fourth-quarter 2025 revenue of US$138 million to US$140 million and full-year 2025 revenue of US$515 million to US$517 million, alongside an outlook for 2026 revenue of US$570 million to US$582 million. The company also highlighted expected adjusted EBITDA margins around 25% and plans to launch Prosigna and its TrueMRD platform in the US, underscoring its focus on expanding its cancer...
NasdaqGS:HBAN
NasdaqGS:HBANBanks

A Look At Huntington Bancshares (HBAN) Valuation As Regional Bank Dividend Appeal Draws Fresh Attention

Interest in Huntington Bancshares (HBAN) has picked up as investors refocus on regional banks that have handled recent interest rate shifts while still appealing to dividend seekers looking for bank exposure. See our latest analysis for Huntington Bancshares. At a latest share price of US$17.68, Huntington’s 15.0% 3 month share price return and 7.8% 1 year total shareholder return point to momentum that has been building rather than fading, as investors reassess regional banks after the...
NasdaqGS:CTAS
NasdaqGS:CTASCommercial Services

A Look At Cintas (CTAS) Valuation After Wells Fargo Upgrade To Overweight

Wells Fargo’s upgrade of Cintas (CTAS) from Equal-Weight to Overweight has put fresh attention on the uniform and business services provider, as investors reassess sentiment around the stock. See our latest analysis for Cintas. The Wells Fargo upgrade comes after a steady build in share price momentum, with Cintas’ 7 day share price return of 4.03% and 90 day return of 5.35% supporting a longer term 3 year total shareholder return of 82.05%. If this kind of steady compounding interests you,...
NYSE:WFC
NYSE:WFCBanks

Wells Fargo (WFC) Margin Improvement Tests Bullish Narratives After FY 2025 Earnings

Wells Fargo (WFC) just wrapped up FY 2025 with Q4 revenue of US$20.3b and basic EPS of US$1.64, anchored by quarterly net income of US$5.1b. Over the past few quarters, the bank has seen revenue move from US$19.3b in Q4 2024 to US$19.2b in Q1 2025, US$19.8b in Q2, US$20.8b in Q3 and US$20.3b in Q4. EPS tracked from US$1.45 to US$1.41, US$1.61, US$1.68 and US$1.64 over the same stretch. This sets up a year where margins and profitability sit squarely in focus for investors. See our full...
NYSE:ZTO
NYSE:ZTOLogistics

Assessing ZTO Express (NYSE:ZTO) Valuation As Strong Margins And Returns Draw Value Investor Interest

Recent commentary around ZTO Express (Cayman) (ZTO) has focused on its earnings profile, which observers describe as supported by strong operating margins and high returns on invested capital. This combination is drawing fresh attention from value oriented investors. See our latest analysis for ZTO Express (Cayman). ZTO’s recent share price move to $22.50 comes after a 90 day share price return of 18.55%, while the 1 year total shareholder return of 26.88% contrasts with weaker 3 and 5 year...
NasdaqGS:NTAP
NasdaqGS:NTAPTech

Assessing NetApp (NTAP) Valuation After Paul Fipps Joins The Board To Support AI Infrastructure Goals

NetApp (NTAP) has drawn fresh investor attention after appointing Paul Fipps, President of Global Customer Operations at ServiceNow, to its Board of Directors. The move highlights a focus on AI driven data infrastructure and customer centric execution. See our latest analysis for NetApp. NetApp shares trade at US$107.67, with a 7 day share price return of 3.22% partially offsetting a 30 day share price return decline of 5.64%. The 3 year total shareholder return of 76.86% contrasts with a 1...
NYSE:SVV
NYSE:SVVMultiline Retail

A Look At Savers Value Village (SVV) Valuation After Strong Preliminary Sales And 2025 Outlook Reaffirmation

Why the latest sales update matters for Savers Value Village (SVV) Savers Value Village (SVV) has drawn fresh attention after reporting preliminary net sales for its fourth quarter and fiscal 2025, alongside an update on share repurchases and upcoming investor conference participation. See our latest analysis for Savers Value Village. The preliminary sales update and active buyback program appear to have shifted sentiment, with a 10.2% 7 day share price return and 10.9% year to date share...
NYSE:UBER
NYSE:UBERTransportation

Is Uber Technologies (UBER) Pricing Reflect Its Ride Hailing And Delivery Growth Prospects

Wondering if Uber Technologies at around US$84.65 is offering good value or asking too much? This article walks through the key numbers so you can judge that for yourself. Over the last week the stock recorded a 1.8% decline, while the 30 day return is 3.4% and the 1 year return sits at 26.3%. A very large 3 year return and a 5 year return of 50.1% are also shaping how investors are thinking about risk and opportunity. Recent headlines have focused on Uber's position as a large player in...
NasdaqGS:NTRA
NasdaqGS:NTRABiotechs

Is It Too Late To Consider Natera (NTRA) After Its Strong 1-Year Share Price Run?

If you are wondering whether Natera's current share price lines up with its underlying value, you are not alone. This article is built to help you connect the dots. Natera's stock closed at US$239.19, with returns of 4.5% year to date and about 42% over the past year. The last week showed a small 0.2% decline, the past month showed a 5.2% gain, and the three year figure is very large. Recent attention on Natera has been shaped by company specific developments and sector wide interest in...
NasdaqCM:SEZL
NasdaqCM:SEZLDiversified Financial

How Sezzle’s Surging Revenue and EPS Growth Will Impact Sezzle (SEZL) Investors

In recent updates, Sezzle reported that its payment platform, which lets shoppers split purchases into four interest-free installments over six weeks, has delivered annual revenue growth of 67.8% over the last two years, alongside very large annual earnings per share growth of 173%. The fact that earnings are growing much faster than revenue suggests Sezzle’s incremental sales have become highly profitable, pointing to improving operational efficiency and stronger monetization of its...
NYSE:DK
NYSE:DKOil and Gas

A Look At Delek US Holdings (DK) Valuation After Recent Share Price Weakness

Why Delek US Holdings is on investor radars today Delek US Holdings (DK) has drawn attention after recent share price moves, with the stock up 1.9% over the past week but showing a decline over the past month and over the past 3 months. See our latest analysis for Delek US Holdings. Zooming out, Delek US Holdings has a 30 day share price return of an 11.27% decline and a 90 day share price return of an 8.69% decline. However, its 1 year total shareholder return of 56.23% and 5 year total...
NasdaqGS:HUT
NasdaqGS:HUTSoftware

Hut 8 (HUT) Valuation Check As AI Data Center Plan And Expanded Credit Facility Draw Attention

Hut 8 (HUT) is back in focus after the company expanded its credit facility with Coinbase Credit to up to US$200 million and advanced plans for a US$7 billion AI data center in Louisiana. See our latest analysis for Hut 8. Those announcements come after Hut 8 hit a 52 week high of US$62.78. Despite a 5.06% one day share price return decline, the 30 day share price return of 64.70% and 1 year total shareholder return of 122.28% suggest momentum has been strong rather than fading. If you are...
NYSE:S
NYSE:SSoftware

Is SentinelOne (S) Now Attractive After A 34.7% One Year Share Price Decline

If you are wondering whether SentinelOne's share price reflects its true worth, you are not alone. Many investors are trying to work out what a fair value looks like for this cybersecurity name. The stock last closed at US$14.22, with returns of an 8.4% decline over 7 days, a 4.2% decline over 30 days, a 2.9% decline year to date and a 34.7% decline over the past year, while the 3-year return sits at 1.5%. Recent coverage around SentinelOne has focused on how market sentiment toward higher...
NYSE:TPR
NYSE:TPRLuxury

How Investors May Respond To Tapestry (TPR) Downgrade Amid Earnings And Gen Z Demand Focus

In recent days, Jefferies downgraded Tapestry to Hold from Buy, arguing that much of the near-term upside is already reflected in the stock after its strong prior rally, while also highlighting potential catalysts such as a strong December quarter and any future repeal of tariffs alongside risks like tougher price comparisons, softer brand momentum, and rising discounting. At the same time, analysts are watching Tapestry’s upcoming fiscal second-quarter earnings, where expectations for...
NYSE:TKR
NYSE:TKRMachinery

What Timken (TKR)'s New CTO Role and Regional Leadership Shuffle Means For Shareholders

In early January 2026, The Timken Company reshaped its leadership by creating a chief technology officer role and appointing new regional presidents across the Americas and Europe to sharpen its technology focus and regional execution. By elevating technology, AI and automation to the C-suite, Timken is signaling that enterprise-wide innovation and data-driven decisions are becoming central to its push for organic growth. Next, we’ll examine how Timken’s new chief technology officer role...